UBS Group’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16M | Sell |
252,582
-19,526
| -7% | -$1.23M | ﹤0.01% | 2055 |
|
|
2025
Q1 | $14.4M | Buy |
272,108
+17,844
| +7% | +$945K | ﹤0.01% | 2048 |
|
|
2024
Q4 | $14.2M | Buy |
254,264
+177,630
| +232% | +$9.94M | ﹤0.01% | 2048 |
|
|
2024
Q3 | $4.01M | Buy |
76,634
+10,692
| +16% | +$560K | ﹤0.01% | 2462 |
|
|
2024
Q2 | $2.71M | Sell |
65,942
-105,623
| -62% | -$4.34M | ﹤0.01% | 2583 |
|
|
2024
Q1 | $7.43M | Buy |
171,565
+85,610
| +100% | +$3.71M | ﹤0.01% | 1832 |
|
|
2023
Q4 | $3.95M | Buy |
85,955
+59,304
| +223% | +$2.73M | ﹤0.01% | 2214 |
|
|
2023
Q3 | $611K | Sell |
26,651
-61,198
| -70% | -$1.4M | ﹤0.01% | 3470 |
|
|
2023
Q2 | $1.45M | Buy |
87,849
+3,772
| +4% | +$62.2K | ﹤0.01% | 2967 |
|
|
2023
Q1 | $1.5M | Sell |
84,077
-107,188
| -56% | -$1.91M | ﹤0.01% | 2842 |
|
|
2022
Q4 | $5.57M | Buy |
191,265
+178,630
| +1,414% | +$5.2M | ﹤0.01% | 1751 |
|
|
2022
Q3 | $309K | Buy |
12,635
+5,128
| +68% | +$125K | ﹤0.01% | 3753 |
|
|
2022
Q2 | $31K | Buy |
7,507
+7,007
| +1,401% | +$28.9K | ﹤0.01% | 5339 |
|
|
2022
Q1 | $6K | Sell |
500
-103,080
| -100% | -$1.24M | ﹤0.01% | 7929 |
|
|
2021
Q4 | $1.03M | Buy |
103,580
+22,610
| +28% | +$226K | ﹤0.01% | 3423 |
|
|
2021
Q3 | $1.06M | Buy |
80,970
+851
| +1% | +$11.1K | ﹤0.01% | 3225 |
|
|
2021
Q2 | $1.57M | Sell |
80,119
-46,731
| -37% | -$915K | ﹤0.01% | 2920 |
|
|
2021
Q1 | $2.7M | Buy |
126,850
+25,699
| +25% | +$547K | ﹤0.01% | 2492 |
|
|
2020
Q4 | $3.01M | Buy |
101,151
+58,894
| +139% | +$1.75M | ﹤0.01% | 2274 |
|
|
2020
Q3 | $916K | Buy |
42,257
+42,011
| +17,078% | +$911K | ﹤0.01% | 2976 |
|
|
2020
Q2 | $5K | Sell |
246
-5,579
| -96% | -$113K | ﹤0.01% | 6524 |
|
|
2020
Q1 | $89K | Buy |
5,825
+4,084
| +235% | +$62.4K | ﹤0.01% | 4527 |
|
|
2019
Q4 | $40K | Sell |
1,741
-33,231
| -95% | -$763K | ﹤0.01% | 5426 |
|
|
2019
Q3 | $755K | Buy |
34,972
+34,216
| +4,526% | +$739K | ﹤0.01% | 3414 |
|
|
2019
Q2 | $17K | Buy |
756
+570
| +306% | +$12.8K | ﹤0.01% | 5856 |
|
|
2019
Q1 | $5K | Sell |
186
-10,178
| -98% | -$274K | ﹤0.01% | 6340 |
|
|
2018
Q4 | $279K | Buy |
10,364
+5,408
| +109% | +$146K | ﹤0.01% | 3873 |
|
|
2018
Q3 | $145K | Buy |
4,956
+2,389
| +93% | +$69.9K | ﹤0.01% | 4437 |
|
|
2018
Q2 | $80K | Buy |
2,567
+1,624
| +172% | +$50.6K | ﹤0.01% | 4727 |
|
|
2018
Q1 | $19K | Sell |
943
-7,909
| -89% | -$159K | ﹤0.01% | 5574 |
|
|
2017
Q4 | $257K | Buy |
+8,852
| New | +$257K | ﹤0.01% | 3865 |
|